Drug profile · INN
emtricitabine, tenofovir alafenamide
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
emtricitabine, tenofovir alafenamide (EMTRICITABINE AND TENOFOVIR ALAFENAMIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — emtricitabine, tenofovir alafenamide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
emtricitabine, tenofovir alafenamide (EMTRICITABINE AND TENOFOVIR ALAFENAMIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is emtricitabine, tenofovir alafenamide?
emtricitabine, tenofovir alafenamide (EMTRICITABINE AND TENOFOVIR ALAFENAMIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for emtricitabine, tenofovir alafenamide?
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE is a marketed brand name for emtricitabine, tenofovir alafenamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of emtricitabine, tenofovir alafenamide?
emtricitabine, tenofovir alafenamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.